Ethical approval for controlled human infectious model clinical trial protocols – A workshop report Article Swipe
Euzebiusz Jamrozik
,
Katherine Littler
,
Irina Meln
,
Wim Van Molle
,
Sandra Morel
,
Ole F. Olesen
,
Michelle Rubbrecht
,
Shobana Balasingam
,
Pieter Neels
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/j.biologicals.2024.101748
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/j.biologicals.2024.101748
Controlled Human Infectious Model studies (CHIM) involve deliberately exposing volunteers to pathogens. To discuss ethical issues related to CHIM, the European Vaccine Initiative and the International Alliance for Biological Standardization organised the workshop "Ethical Approval for CHIM Clinical Trial Protocols", which took place on May 30-31, 2023, in Brussels, Belgium. The event allowed CHIM researchers, regulators, ethics committee (EC) members, and ethicists to examine the ethical criteria for CHIM and the role(s) of CHIM in pharmaceutical development. The discussions led to several recommendations, including continued assurance that routine ethical requirements are met, assurance that participants are well-informed, and that preparation of study documents must be both ethically and scientifically sound from an early stage. Study applications must clearly state the rationale for the challenge compared to alternative study designs. ECs need to have clear guidance and procedures for evaluating social value and assessing third-party risks. Among other things, public trust in research requires minimisation of harm to healthy volunteers and third-party risk. Other important considerations include appropriate stakeholder engagement, public education, and access to health care for participants after the study.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.biologicals.2024.101748
- OA Status
- hybrid
- Cited By
- 4
- References
- 23
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4391744693
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4391744693Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.biologicals.2024.101748Digital Object Identifier
- Title
-
Ethical approval for controlled human infectious model clinical trial protocols – A workshop reportWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-02-01Full publication date if available
- Authors
-
Euzebiusz Jamrozik, Katherine Littler, Irina Meln, Wim Van Molle, Sandra Morel, Ole F. Olesen, Michelle Rubbrecht, Shobana Balasingam, Pieter NeelsList of authors in order
- Landing page
-
https://doi.org/10.1016/j.biologicals.2024.101748Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.biologicals.2024.101748Direct OA link when available
- Concepts
-
Clinical trial, Medical physics, Medicine, PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
4Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3, 2024: 1Per-year citation counts (last 5 years)
- References (count)
-
23Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4391744693 |
|---|---|
| doi | https://doi.org/10.1016/j.biologicals.2024.101748 |
| ids.doi | https://doi.org/10.1016/j.biologicals.2024.101748 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38350349 |
| ids.openalex | https://openalex.org/W4391744693 |
| fwci | 3.0252612 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D012107 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Research Design |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D064368 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Healthy Volunteers |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000076722 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Drug Development |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D006801 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Humans |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D012107 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Research Design |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D064368 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Healthy Volunteers |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000076722 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Drug Development |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D006801 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Humans |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D012107 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Research Design |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D064368 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Healthy Volunteers |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000076722 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Drug Development |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D012107 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Research Design |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D064368 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Healthy Volunteers |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D000076722 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Drug Development |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D006801 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Humans |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D012107 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Research Design |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D064368 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Healthy Volunteers |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D000076722 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Drug Development |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D006801 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Humans |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D012107 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Research Design |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D064368 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Healthy Volunteers |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D000076722 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Drug Development |
| type | article |
| title | Ethical approval for controlled human infectious model clinical trial protocols – A workshop report |
| biblio.issue | |
| biblio.volume | 85 |
| biblio.last_page | 101748 |
| biblio.first_page | 101748 |
| grants[0].funder | https://openalex.org/F4320314178 |
| grants[0].award_id | |
| grants[0].funder_display_name | European Federation of Pharmaceutical Industries and Associations |
| grants[1].funder | https://openalex.org/F4320319491 |
| grants[1].award_id | 101007799 |
| grants[1].funder_display_name | Innovative Health Initiative |
| grants[2].funder | https://openalex.org/F4320320300 |
| grants[2].award_id | |
| grants[2].funder_display_name | European Commission |
| grants[3].funder | https://openalex.org/F4320326631 |
| grants[3].award_id | |
| grants[3].funder_display_name | Innovative Medicines Initiative |
| topics[0].id | https://openalex.org/T13417 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9887999892234802 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2737 |
| topics[0].subfield.display_name | Physiology |
| topics[0].display_name | Biomedical Ethics and Regulation |
| topics[1].id | https://openalex.org/T10582 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9793999791145325 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2739 |
| topics[1].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[1].display_name | Ethics in Clinical Research |
| topics[2].id | https://openalex.org/T10804 |
| topics[2].field.id | https://openalex.org/fields/20 |
| topics[2].field.display_name | Economics, Econometrics and Finance |
| topics[2].score | 0.9609000086784363 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2002 |
| topics[2].subfield.display_name | Economics and Econometrics |
| topics[2].display_name | Health Systems, Economic Evaluations, Quality of Life |
| funders[0].id | https://openalex.org/F4320314178 |
| funders[0].ror | https://ror.org/00g1x4v36 |
| funders[0].display_name | European Federation of Pharmaceutical Industries and Associations |
| funders[1].id | https://openalex.org/F4320319491 |
| funders[1].ror | |
| funders[1].display_name | Innovative Health Initiative |
| funders[2].id | https://openalex.org/F4320320300 |
| funders[2].ror | https://ror.org/00k4n6c32 |
| funders[2].display_name | European Commission |
| funders[3].id | https://openalex.org/F4320326631 |
| funders[3].ror | https://ror.org/019af4n30 |
| funders[3].display_name | Innovative Medicines Initiative |
| is_xpac | False |
| apc_list.value | 3000 |
| apc_list.currency | USD |
| apc_list.value_usd | 3000 |
| apc_paid.value | 3000 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3000 |
| concepts[0].id | https://openalex.org/C535046627 |
| concepts[0].level | 2 |
| concepts[0].score | 0.5695281624794006 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[0].display_name | Clinical trial |
| concepts[1].id | https://openalex.org/C19527891 |
| concepts[1].level | 1 |
| concepts[1].score | 0.47122159600257874 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1120908 |
| concepts[1].display_name | Medical physics |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.45984944701194763 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C142724271 |
| concepts[3].level | 1 |
| concepts[3].score | 0.20242315530776978 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[3].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/clinical-trial |
| keywords[0].score | 0.5695281624794006 |
| keywords[0].display_name | Clinical trial |
| keywords[1].id | https://openalex.org/keywords/medical-physics |
| keywords[1].score | 0.47122159600257874 |
| keywords[1].display_name | Medical physics |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.45984944701194763 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/pathology |
| keywords[3].score | 0.20242315530776978 |
| keywords[3].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1016/j.biologicals.2024.101748 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S110177920 |
| locations[0].source.issn | 1045-1056, 1095-8320 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1045-1056 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Biologicals |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Biologicals |
| locations[0].landing_page_url | https://doi.org/10.1016/j.biologicals.2024.101748 |
| locations[1].id | pmid:38350349 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Biologicals : journal of the International Association of Biological Standardization |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38350349 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11004724 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Biologicals |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11004724 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5000358006 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5940-602X |
| authorships[0].author.display_name | Euzebiusz Jamrozik |
| authorships[0].countries | GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I40120149, https://openalex.org/I4210162189 |
| authorships[0].affiliations[0].raw_affiliation_string | The Ethox Centre & Wellcome Centre for Ethics and Humanities, University of Oxford, Oxford, United Kingdom |
| authorships[0].institutions[0].id | https://openalex.org/I40120149 |
| authorships[0].institutions[0].ror | https://ror.org/052gg0110 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I40120149 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | University of Oxford |
| authorships[0].institutions[1].id | https://openalex.org/I4210162189 |
| authorships[0].institutions[1].ror | https://ror.org/05crdvn36 |
| authorships[0].institutions[1].type | facility |
| authorships[0].institutions[1].lineage | https://openalex.org/I40120149, https://openalex.org/I4210162189, https://openalex.org/I87048295 |
| authorships[0].institutions[1].country_code | GB |
| authorships[0].institutions[1].display_name | Wellcome Centre for Ethics and Humanities |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Euzebiusz Jamrozik |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | The Ethox Centre & Wellcome Centre for Ethics and Humanities, University of Oxford, Oxford, United Kingdom |
| authorships[1].author.id | https://openalex.org/A5074350243 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3679-6031 |
| authorships[1].author.display_name | Katherine Littler |
| authorships[1].countries | CH |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210105654 |
| authorships[1].affiliations[0].raw_affiliation_string | Health Ethics and Governance Unit, Research for Health Department, Science Division, World Health Organization, Geneva, Switzerland |
| authorships[1].institutions[0].id | https://openalex.org/I4210105654 |
| authorships[1].institutions[0].ror | https://ror.org/01f80g185 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210105654 |
| authorships[1].institutions[0].country_code | CH |
| authorships[1].institutions[0].display_name | World Health Organization |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Katherine Littler |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Health Ethics and Governance Unit, Research for Health Department, Science Division, World Health Organization, Geneva, Switzerland |
| authorships[2].author.id | https://openalex.org/A5027205163 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-5737-4167 |
| authorships[2].author.display_name | Irina Meln |
| authorships[2].countries | DE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210136500 |
| authorships[2].affiliations[0].raw_affiliation_string | European Vaccine Initiative, Heidelberg, Germany |
| authorships[2].institutions[0].id | https://openalex.org/I4210136500 |
| authorships[2].institutions[0].ror | https://ror.org/03n1zj511 |
| authorships[2].institutions[0].type | nonprofit |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210136500 |
| authorships[2].institutions[0].country_code | DE |
| authorships[2].institutions[0].display_name | Vienna Vaccine Safety Initiative |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Irina Meln |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | European Vaccine Initiative, Heidelberg, Germany |
| authorships[3].author.id | https://openalex.org/A5006567399 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8587-7850 |
| authorships[3].author.display_name | Wim Van Molle |
| authorships[3].countries | BE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210145009 |
| authorships[3].affiliations[0].raw_affiliation_string | Sciensano, Brussels, Belgium |
| authorships[3].institutions[0].id | https://openalex.org/I4210145009 |
| authorships[3].institutions[0].ror | https://ror.org/04ejags36 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210145009 |
| authorships[3].institutions[0].country_code | BE |
| authorships[3].institutions[0].display_name | Sciensano (Belgium) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Wim Van Molle |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Sciensano, Brussels, Belgium |
| authorships[4].author.id | https://openalex.org/A5093854654 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Sandra Morel |
| authorships[4].countries | BE |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210095529 |
| authorships[4].affiliations[0].raw_affiliation_string | Glaxosmithkline (GSK), Rixensart, Belgium |
| authorships[4].institutions[0].id | https://openalex.org/I4210095529 |
| authorships[4].institutions[0].ror | https://ror.org/00n3pea85 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I188950975, https://openalex.org/I4210095529 |
| authorships[4].institutions[0].country_code | BE |
| authorships[4].institutions[0].display_name | GlaxoSmithKline (Belgium) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Sandra Morel |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Glaxosmithkline (GSK), Rixensart, Belgium |
| authorships[5].author.id | https://openalex.org/A5000969347 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-3025-2466 |
| authorships[5].author.display_name | Ole F. Olesen |
| authorships[5].countries | DE |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210136500 |
| authorships[5].affiliations[0].raw_affiliation_string | European Vaccine Initiative, Heidelberg, Germany |
| authorships[5].institutions[0].id | https://openalex.org/I4210136500 |
| authorships[5].institutions[0].ror | https://ror.org/03n1zj511 |
| authorships[5].institutions[0].type | nonprofit |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210136500 |
| authorships[5].institutions[0].country_code | DE |
| authorships[5].institutions[0].display_name | Vienna Vaccine Safety Initiative |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Ole F. Olesen |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | European Vaccine Initiative, Heidelberg, Germany |
| authorships[6].author.id | https://openalex.org/A5083785481 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-0113-1323 |
| authorships[6].author.display_name | Michelle Rubbrecht |
| authorships[6].affiliations[0].raw_affiliation_string | P95 Epidemiology & Pharmacovigilance, Leuven, Belgium |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Michelle Rubbrecht |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | P95 Epidemiology & Pharmacovigilance, Leuven, Belgium |
| authorships[7].author.id | https://openalex.org/A5078897072 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8112-1813 |
| authorships[7].author.display_name | Shobana Balasingam |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I87048295 |
| authorships[7].affiliations[0].raw_affiliation_string | Wellcome Trust, London, United Kingdom |
| authorships[7].institutions[0].id | https://openalex.org/I87048295 |
| authorships[7].institutions[0].ror | https://ror.org/029chgv08 |
| authorships[7].institutions[0].type | nonprofit |
| authorships[7].institutions[0].lineage | https://openalex.org/I87048295 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | Wellcome Trust |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Shobana Balasingam |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Wellcome Trust, London, United Kingdom |
| authorships[8].author.id | https://openalex.org/A5037051761 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Pieter Neels |
| authorships[8].affiliations[0].raw_affiliation_string | International Alliance for Biological Standardization (IABS), Lyon, France |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | Pieter Neels |
| authorships[8].is_corresponding | True |
| authorships[8].raw_affiliation_strings | International Alliance for Biological Standardization (IABS), Lyon, France |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.biologicals.2024.101748 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Ethical approval for controlled human infectious model clinical trial protocols – A workshop report |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T13417 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9887999892234802 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2737 |
| primary_topic.subfield.display_name | Physiology |
| primary_topic.display_name | Biomedical Ethics and Regulation |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725 |
| cited_by_count | 4 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1016/j.biologicals.2024.101748 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S110177920 |
| best_oa_location.source.issn | 1045-1056, 1095-8320 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1045-1056 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Biologicals |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Biologicals |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.biologicals.2024.101748 |
| primary_location.id | doi:10.1016/j.biologicals.2024.101748 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S110177920 |
| primary_location.source.issn | 1045-1056, 1095-8320 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1045-1056 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Biologicals |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Biologicals |
| primary_location.landing_page_url | https://doi.org/10.1016/j.biologicals.2024.101748 |
| publication_date | 2024-02-01 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4304206958, https://openalex.org/W1969834934, https://openalex.org/W2338736253, https://openalex.org/W2910615591, https://openalex.org/W4221135099, https://openalex.org/W3021390017, https://openalex.org/W3204361907, https://openalex.org/W1017348960, https://openalex.org/W4212941893, https://openalex.org/W3185642830, https://openalex.org/W4294052424, https://openalex.org/W3094542430, https://openalex.org/W4380200158, https://openalex.org/W3109372863, https://openalex.org/W3045013662, https://openalex.org/W2905439315, https://openalex.org/W2339874559, https://openalex.org/W2090155117, https://openalex.org/W3097114738, https://openalex.org/W3205215480, https://openalex.org/W3200770050, https://openalex.org/W3190947740, https://openalex.org/W2948253547 |
| referenced_works_count | 23 |
| abstract_inverted_index.To | 12 |
| abstract_inverted_index.an | 111 |
| abstract_inverted_index.be | 104 |
| abstract_inverted_index.in | 47, 74, 150 |
| abstract_inverted_index.of | 72, 100, 154 |
| abstract_inverted_index.on | 43 |
| abstract_inverted_index.to | 10, 17, 62, 80, 125, 131, 156, 173 |
| abstract_inverted_index.ECs | 129 |
| abstract_inverted_index.May | 44 |
| abstract_inverted_index.The | 50, 77 |
| abstract_inverted_index.and | 23, 60, 69, 97, 107, 135, 141, 159, 171 |
| abstract_inverted_index.are | 90, 95 |
| abstract_inverted_index.for | 27, 35, 67, 121, 137, 176 |
| abstract_inverted_index.led | 79 |
| abstract_inverted_index.the | 19, 24, 31, 64, 70, 119, 122, 179 |
| abstract_inverted_index.(EC) | 58 |
| abstract_inverted_index.CHIM | 36, 53, 68, 73 |
| abstract_inverted_index.both | 105 |
| abstract_inverted_index.care | 175 |
| abstract_inverted_index.from | 110 |
| abstract_inverted_index.harm | 155 |
| abstract_inverted_index.have | 132 |
| abstract_inverted_index.met, | 91 |
| abstract_inverted_index.must | 103, 116 |
| abstract_inverted_index.need | 130 |
| abstract_inverted_index.that | 86, 93, 98 |
| abstract_inverted_index.took | 41 |
| abstract_inverted_index.2023, | 46 |
| abstract_inverted_index.Among | 145 |
| abstract_inverted_index.CHIM, | 18 |
| abstract_inverted_index.Human | 1 |
| abstract_inverted_index.Model | 3 |
| abstract_inverted_index.Other | 162 |
| abstract_inverted_index.Study | 114 |
| abstract_inverted_index.Trial | 38 |
| abstract_inverted_index.after | 178 |
| abstract_inverted_index.clear | 133 |
| abstract_inverted_index.early | 112 |
| abstract_inverted_index.event | 51 |
| abstract_inverted_index.other | 146 |
| abstract_inverted_index.place | 42 |
| abstract_inverted_index.risk. | 161 |
| abstract_inverted_index.sound | 109 |
| abstract_inverted_index.state | 118 |
| abstract_inverted_index.study | 101, 127 |
| abstract_inverted_index.trust | 149 |
| abstract_inverted_index.value | 140 |
| abstract_inverted_index.which | 40 |
| abstract_inverted_index.(CHIM) | 5 |
| abstract_inverted_index.30-31, | 45 |
| abstract_inverted_index.access | 172 |
| abstract_inverted_index.ethics | 56 |
| abstract_inverted_index.health | 174 |
| abstract_inverted_index.issues | 15 |
| abstract_inverted_index.public | 148, 169 |
| abstract_inverted_index.risks. | 144 |
| abstract_inverted_index.social | 139 |
| abstract_inverted_index.stage. | 113 |
| abstract_inverted_index.study. | 180 |
| abstract_inverted_index.Vaccine | 21 |
| abstract_inverted_index.allowed | 52 |
| abstract_inverted_index.clearly | 117 |
| abstract_inverted_index.discuss | 13 |
| abstract_inverted_index.ethical | 14, 65, 88 |
| abstract_inverted_index.examine | 63 |
| abstract_inverted_index.healthy | 157 |
| abstract_inverted_index.include | 165 |
| abstract_inverted_index.involve | 6 |
| abstract_inverted_index.related | 16 |
| abstract_inverted_index.role(s) | 71 |
| abstract_inverted_index.routine | 87 |
| abstract_inverted_index.several | 81 |
| abstract_inverted_index.studies | 4 |
| abstract_inverted_index.things, | 147 |
| abstract_inverted_index."Ethical | 33 |
| abstract_inverted_index.Alliance | 26 |
| abstract_inverted_index.Approval | 34 |
| abstract_inverted_index.Belgium. | 49 |
| abstract_inverted_index.Clinical | 37 |
| abstract_inverted_index.European | 20 |
| abstract_inverted_index.compared | 124 |
| abstract_inverted_index.criteria | 66 |
| abstract_inverted_index.designs. | 128 |
| abstract_inverted_index.exposing | 8 |
| abstract_inverted_index.guidance | 134 |
| abstract_inverted_index.members, | 59 |
| abstract_inverted_index.requires | 152 |
| abstract_inverted_index.research | 151 |
| abstract_inverted_index.workshop | 32 |
| abstract_inverted_index.Brussels, | 48 |
| abstract_inverted_index.assessing | 142 |
| abstract_inverted_index.assurance | 85, 92 |
| abstract_inverted_index.challenge | 123 |
| abstract_inverted_index.committee | 57 |
| abstract_inverted_index.continued | 84 |
| abstract_inverted_index.documents | 102 |
| abstract_inverted_index.ethically | 106 |
| abstract_inverted_index.ethicists | 61 |
| abstract_inverted_index.important | 163 |
| abstract_inverted_index.including | 83 |
| abstract_inverted_index.organised | 30 |
| abstract_inverted_index.rationale | 120 |
| abstract_inverted_index.Biological | 28 |
| abstract_inverted_index.Controlled | 0 |
| abstract_inverted_index.Infectious | 2 |
| abstract_inverted_index.Initiative | 22 |
| abstract_inverted_index.education, | 170 |
| abstract_inverted_index.evaluating | 138 |
| abstract_inverted_index.pathogens. | 11 |
| abstract_inverted_index.procedures | 136 |
| abstract_inverted_index.volunteers | 9, 158 |
| abstract_inverted_index.Protocols", | 39 |
| abstract_inverted_index.alternative | 126 |
| abstract_inverted_index.appropriate | 166 |
| abstract_inverted_index.discussions | 78 |
| abstract_inverted_index.engagement, | 168 |
| abstract_inverted_index.preparation | 99 |
| abstract_inverted_index.regulators, | 55 |
| abstract_inverted_index.stakeholder | 167 |
| abstract_inverted_index.third-party | 143, 160 |
| abstract_inverted_index.applications | 115 |
| abstract_inverted_index.deliberately | 7 |
| abstract_inverted_index.development. | 76 |
| abstract_inverted_index.minimisation | 153 |
| abstract_inverted_index.participants | 94, 177 |
| abstract_inverted_index.requirements | 89 |
| abstract_inverted_index.researchers, | 54 |
| abstract_inverted_index.International | 25 |
| abstract_inverted_index.considerations | 164 |
| abstract_inverted_index.pharmaceutical | 75 |
| abstract_inverted_index.scientifically | 108 |
| abstract_inverted_index.well-informed, | 96 |
| abstract_inverted_index.Standardization | 29 |
| abstract_inverted_index.recommendations, | 82 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 90 |
| corresponding_author_ids | https://openalex.org/A5037051761 |
| countries_distinct_count | 4 |
| institutions_distinct_count | 9 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/17 |
| sustainable_development_goals[0].score | 0.41999998688697815 |
| sustainable_development_goals[0].display_name | Partnerships for the goals |
| citation_normalized_percentile.value | 0.83851729 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |